News
Arbutus Biopharma Corporation (Nasdaq: ABUS) announced the acceptance of five abstracts, including a late-breaking study, for ...
--(BUSINESS WIRE)--ClearB Therapeutics, Inc., a company developing therapeutic vaccines ... “Chronic Hepatitis B (CHB) infection remains a substantial global health care problem in need of ...
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people around the world achieve their financial goals through our investing services and financial advice.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results